A Phase 3, Randomized, Open-Label, Parallel-Group Study to Compare the Pharmacodynamics, Pharmacokinetics, Efficacy, Safety, Tolerability, and Immunogenicity of Multiple Subcutaneous Injections of Efg
Clinical Trial Grant
Administered By
School of Medicine
Awarded By
Argenx BVBA
Start Date
May 19, 2021
End Date
September 13, 2022
Administered By
School of Medicine
Awarded By
Argenx BVBA
Start Date
May 19, 2021
End Date
September 13, 2022